The fund has the mandate to invest in four sector focused areas Healthcare, Life Sciences, Performance Materials and New Businesses, in alignment with the strategic interests of Merck’s business areas, though formally separated by a “Chinese Wall”. The total volume of the corporate venture fund is € 300 million.
The Healthcare fund is the strategic, corporate venture arm of the biopharmaceutical division of Merck. We invest globally in emerging biotechnology companies that develop products and or technologies that have the potential to significantly improve patient outcomes.
Along with the Merck Healthcare commitment, our team also manages the Entrepreneur Partnership Program which was established to support the creation of spin-offs from Merck and the Israel Bioincubator, which is focused on pre-seed and seed opportunities coming out of Israel.
The M Ventures Israel Bioincubator is a strategic initiative designed to stimulate innovation by bridging the gap between academic research and the biotechnology industry in Israel. Launched in 2011 to offers invest in biomedical innovation in Israel, the Bioincubator both seed financing and access to dedicated laboratory facilities within our Israel based R&D center.
The Life Science Team invests in areas of strategic value to the life science division of Merck.
We invest globally in emerging life science companies that develop products, services and or technologies that have the potential to make research and biotech production easier, faster, more successful and enhance customer service. The Life Science team helps driving better solutions for our customers.
The Electronics Fund is the strategic, corporate venture arm of the performance materials division of Merck.
Discovering and unleashing the most innovative startups in the Electronics sector, the fund targets companies developing applications and solutions for the future of computing, data storage, display and device miniaturization.
The New Businesses Fund is the strategic, corporate venture arm of Merck.
This fund exists to pursue interdisciplinary approaches with opportunities that serve multiple business sectors or have a strong element of technology convergence. The Frontier Tech and Sustainability fund is looking for novel technologies, services and business models that can positively impact the sustainability of both Merck and our customers, be that via novel production of materials or through innovations in the application of digital technologies.
